Users of retail medications for opioid use disorders faced high out-of-pocket prescription spending in 2011–2017

Abraham, 2017, The affordable care act transformation of substance use disorder treatment, American Journal of Public Health, 107, 31, 10.2105/AJPH.2016.303558 Abraham, 2018, Geographic disparities in availability of opioid use disorder treatment for medicaid enrollees, Health Services Research, 53, 389, 10.1111/1475-6773.12686 Center for Behavioral Health Statistics and Quality (CBHSQ), 2019 Dunphy, 2021, Do out-of-pocket costs influence retention and adherence to medications for opioid use disorder?, Drug and Alcohol Dependence, 225, 1 Dusetzina, 2019, Proposals to redesign Medicare Part D—easing the burden of rising drug prices, New England Journal of Medicine, 381, 1401, 10.1056/NEJMp1908688 French, 2016, Key provisions of the patient protection and affordable care act (ACA): A systematic review and presentation of early research findings, Health Services Research, 51, 1735, 10.1111/1475-6773.12511 2019, Opioid use disorder market size, share & trends analysis report by drug (buprenorphine, methadone, naltrexone) Grogan, 2016, Survey highlights differences in Medicaid coverage for substance use treatment and opioid use disorder medications, Health Affairs, 35, 2289, 10.1377/hlthaff.2016.0623 Maclean, 2019, The effect of public insurance expansions on substance use disorder treatment: evidence from the Affordable Care Act, Journal of Policy Analysis and Management, 38, 366, 10.1002/pam.22112 McCollister, 2018, Cost of pharmacotherapy for opioid use disorders following inpatient detoxification, The American Journal of Managed Care, 24, 526 Miller, 2009 Mutter, 2019, Characteristics of individuals who receive pharmacotherapy while in treatment for opioid use disorder in the United States, Addictive Disorders and Their Treatment., 19, 77, 10.1097/ADT.0000000000000185 Olfson, 2020, Trends in buprenorphine treatment in the United States, 2009–2018, Journal of the American Medical Association, 323, 276, 10.1001/jama.2019.18913 Reif, 2016 Saloner, 2015, Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004–2013, Journal of the American Medical Association, 314, 1515, 10.1001/jama.2015.10345 Stein, 2018, A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees, Substance Abuse, 39, 419, 10.1080/08897077.2018.1449166 Wu, 2016, Treatment utilization among persons with opioid use disorder in the United States, Drug and Alcohol Dependence, 109, 117, 10.1016/j.drugalcdep.2016.10.015